Zydus Lifesciences Limited has informed the Exchange about change in Management
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences informed the exchanges that its current CFO and Key Managerial Personnel, Mr. Nitin Parekh, will superannuate (retire) effective August 31, 2025. The Board recorded its appreciation for his contributions to mergers, acquisitions, fundraising, cost rationalisation, and systems development. Mr. Tushar Shroff, who has already joined the company as President-Finance from April 30, 2025, will be appointed as the new CFO and KMP with effect from September 1, 2025. Mr. Shroff is a Chartered Accountant and Cost Accountant, aged 55, with 29+ years of experience including 15+ years as CFO across pharma and technology companies such as Piramal Healthcare, Intas Pharmaceuticals, and Sterlite Technologies. Notably, he had previously worked with Zydus from December 2010 to January 2019, making him a familiar face returning to lead the finance function.
This is a well-planned, orderly succession with no gap in leadership — the incoming CFO is already inside the company as President-Finance and is a returning veteran. Shareholders are unlikely to see any material disruption; if anything, the transition signals continuity rather than a change in strategic direction.